Examining the Activities of Pharmacy and Therapeutics Committees: An Exploratory Study

REFERENCES

• Summers K, Szeinbach S. Formularies: The role of pharmacy and therapeutics (P&T) committees. Clin Ther. 1993; 15:433–9.
   PubMed Web of Science ®Google Scholar
• Weekes L, Brooks C, Day R. Indicators for drugs and therapeutics committees. Brit J Clin Pharmacol. 1998; 45:393–8.
   PubMedGoogle Scholar
• Fijn R, Brouwers JR, Knaap RJ, De Jong-Van Den Berg LT. Drug and therapeu-tics (D&T) committees in Dutch hospitals: A nation-wide survey of structure, activi-ties, and drug selection procedures. Brit J Clin Pharmacol. 1999; 48(2):239–46.
   Google Scholar
• Thurman PA, Harder S, Steiff A. Structure and activities of hospital drug com-mittees in Germany. Eur J Clin Pharmacol. 1997; 52:429–35.
   Google Scholar
• Manasse H. Medication use in an imperfect world: Drug mis-adventuring as an issue of public policy. Am J Health-Syst Pharm. 1989; 46:929–44.
   Web of Science ®Google Scholar
• Vogel D. Patient focused care. Am J Hosp Pharm. 1993; 50:2321–9.
   PubMedGoogle Scholar
• Gordon K. Group judgements in the field of lifted weights. J Exp Psychol. 1924; 7:398–400.
   Google Scholar
• Shaw MA. A comparison of individuals and small groups in the rational solu-tion of complex problems. Am J Psychol. 1932; 44:491–504.
   Google Scholar
• Lewin K. Resolving social conflicts. New York: Harper; 1948.
   Google Scholar
• Bales R. Interaction process analysis: A method for the study of small groups. Cambridge, MA: Addison-Wesley; 1950.
   Google Scholar
• Festinger L. Informal social communication. Psychol Rev. 1950; 57:271–92.
   PubMed Web of Science ®Google Scholar
• Deutsch M. Distributive justice: A social psychological perspective. New Ha-ven, CT: Yale University Press; 1985.
   Google Scholar
• Stasser G, Kerr N, Davis J. Influence processes and consensus models in deci-sion making groups. In: Psychology of group influence. Paulus B, ed. Hillsdale, NJ: Erlbaum; 1989:279–326.
   Google Scholar
• McGrath J. Interaction and performance. Englewood Cliffs, NJ: Prentice-Hall; 1984.
   Google Scholar
• Kolodny H, Kiggundu M. Towards the development of a sociotechnical sys-tems model in woodland mechanical harvesting. Hum Relations. 1980; 33:623–45.
   Web of Science ®Google Scholar
• Gladstein D. Groups in context: A model of task group effectiveness. Admin Sci Q. 1984; 29:499–517.
   Web of Science ®Google Scholar
• Goodman P, Ravlin E, Schminke M. Understanding groups in organizations. In: Research in organizational behavior. Cummings L, Straw B, eds. Greenwich, CT: JAI Press; 1987:121–75.
   Google Scholar
• Shea G, Guzzo R. Group effectiveness: What really matters? Sloan Manage Rev. 1987; 28:25-31.
   Google Scholar
• Pearce J, Ravlin E. The design and activation of self regulating work groups. Hum Relations. 1987; 40:751–82.
   Web of Science ®Google Scholar
• Ancona D, Caldwell D. Beyond task and maintenance: Defining external func-tions in groups. Group Organiz Studies. 1988; 13:468–94.
   Web of Science ®Google Scholar
• Ancona D, Caldwell D. Bridging the boundary: External activity and perfor-mance in organizational teams. Admin Sci Q. 1992; 37:634–65.
   Web of Science ®Google Scholar
• Hackman J. The design of work teams. In: Handbook of organizational behav-ior. Lorsch J, ed. Englewood Cliffs, NJ: Prentice Hall; 1987:315–42.
   Google Scholar
• Mannebach M, Ascione FJ, Gaither C, Bagozzi RP, Cohen I, Ryan M. Activ-ities, functions, and structure of pharmacy and therapeutic committees in large teach-ing hospitals. Am J Health-Syst Pharm. 1999; 56:623–7.
   Google Scholar
• 1998 profiles of U.S. hospitals. Baltimore, MD: HCIA, Inc.; 1997.
   Google Scholar
• Nair KV, Ascione FJ, Mannebach M, Bagozzi RP. An organizational tool to evaluate the determinants of P&T committee performance. J Am Pharm Assoc. 2000; in press.
   Google Scholar
• Barner JC, Thomas J. Participation and influence of individuals and committees that decide on drug availability in HMOs. Am J Health-Syst Pharm. 1998; 55:56–61.
   PubMedGoogle Scholar
• Heemink I, Tabit E, Mar Melero M, Waning B. Review of the functioning of P&T committees in Boston area hospitals. Part 2. P&T. 1999; 24(Jun):264, 267–270, 275–278, 280.
   Google Scholar
• Hillman D. The design and administration of mail surveys. Ann Rev Sociol. 1991; 17:225–49.
   Google Scholar
• Anderson J, Gerbing D. The effect of sampling error on convergence, improper solutions, and goodness-of-fit indices for maximum likelihood confirmatory factor analysis. Psychometrika. 1984; 49:155–73.
   Web of Science ®Google Scholar
• Boomsma A. The robustness of LISREL against small sample sizes in factor analysis models. In: Systems under indirect observation: Causality, structure and pre-diction. Joreskog K, Wold J, eds. New York: North Holland; 1982.
   Google Scholar
• Bagozzi R, Heatherton T. A general approach to representing multifaceted per-sonality constructs: Application to state self-esteem. Structural Equation Model. 1994; 1:35–67.
   Web of Science ®Google Scholar
• Bagozzi R, Yi Y. On the evaluation of structural equation models. J Acad Mar-ket Sci. 1988; 16:74–94.
   Google Scholar
• Nash D, Catalano M, Wordell C. The formulary decision making process in a U.S. academic medical center. Pharmacoeconomics. 1993; 3:22–35.
   Google Scholar
• Pillans P, Conry I, Gie B. Drug cost containment at a large teaching hospital. Pharmacoeconomics. 1992; 1:377–82.
   Google Scholar
• Cano S. Formularies in integrated health systems: Fallon Healthcare System. Am J Health-Syst Pharm. 1996; 1:270–4.
   Google Scholar
• Rizos A, Levy E, Furnier J, Crowley K. Formularies in integrated health sys-tems: Sharp Healthcare. Am J Health-Syst Pharm. 1996; 53:274–8.
   PubMedGoogle Scholar
• Osborne J. Formularies in integrated health systems: Integris Health. Am J Health-Syst Pharm. 1996; 53:278–81.
   PubMedGoogle Scholar
• Gannon K. More power to you. Hosp Pharm Rep. 1998; 12(Feb):18–20.
   Google Scholar
• Dana WJ, McWhinney B. Managing high cost and biotech drugs: Two institu-tions' perspectives. Hosp Form. 1994; 29:639–45.
   Google Scholar
• Arriola E. The changing relationship between health care professionals and the pharmaceutical industry. Hosp Form. 1995; 30:161–9.
   PubMedGoogle Scholar
• Reeder C, Dickson M, Sante11 J. ASHP survey of pharmacy practice in acute care settings-1996. Am J Health-Syst Pharm. 1997; 54:653–69.
   Google Scholar
• Alderfer C. Boundary relations and organizational diagnosis. In: Humanizing organizational behavior. Meltzer M, ed. Springfield, IL: Charles C. Thomas; 1976: 42–175.
   Google Scholar
• Guzzo RA, Shea GP. Group performance and intergroup relations in organiza-tions. In: Handbook of industrial and organizational psychology. Vol. 3. 2nd ed. Dunnette MD, Hough LM, eds. Palo Alto, CA: Consulting Psychologists Press; 1992: 269–313.
   Google Scholar
• Weekes L, Brooks C, Day R. Indicators for drugs and therapeutics committees. Brit J Clin Pharmacol. 1998; 45:393–8.
   PubMedGoogle Scholar